Trident Lifeline Limited received shareholder approval for the appointment of two independent directors and the migration of its equity shares listing from the BSE SME Platform to the main boards of BSE Limited and National Stock Exchange of India Limited. The resolutions were passed via a postal ballot that concluded on July 15, 2026, with 100% of the votes cast in favour of the proposals.

The postal ballot sought approval for three special resolutions. Ms. Smita Kiran Davda and Mr. Sachin Bhandari were appointed as Non-Executive Independent Directors for a term of five consecutive years. The third resolution approved the migration of the company's listing from the SME platform to the main board of both exchanges.

The voting process was conducted through remote e-voting, which was open from June 16, 2026, to July 15, 2026. A total of 75 shareholders participated, casting 8,386,300 votes. All votes were cast in favour of the resolutions, with no votes recorded against them.

The scrutinizer, Mittal V Kothari of M/s. Mittal V Kothari & Associates, confirmed the results. The report noted that for the resolution regarding the migration of listing, the approval was granted in accordance with Regulation 277 of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. This regulation requires that votes cast by public shareholders in favour must be at least two times the votes cast against them, a condition that was met.

The detailed voting results show that the Promoter and Promoter Group held 7,467,200 shares, while public non-institutions held 3,821,400 shares. Public institutions held 644,400 shares but did not participate in the voting. The record date for determining shareholder eligibility was June 5, 2026.

Voting Summary

Trident Lifeline Limited now holds a 58.67% stake in its subsidiary, Trident Mediquip Limited, following a private placement of equity shares to other shareholders. The reduction from a previous holding of 58.84% was disclosed to the exchanges under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The transaction is classified as a related party transaction but was executed on an arm's length basis.

Trident Mediquip Limited, incorporated on October 19, 2019, operates within the medical device industry. The subsidiary has an authorized and paid-up share capital of ₹10,00,00,000, divided into 1,00,00,000 equity shares of ₹10 each. The entity is based in Surat, Gujarat, and its operations are entirely domestic.

The filing confirmed that the private placement involved the allotment of shares to other shareholders, which diluted the parent company's stake. Promoters and promoter group members, including Mr. Amit Bhupendra Halvawala and Mr. Chetan Chandrakant Jariwala, hold interests in the subsidiary. The company stated that no specific governmental or regulatory approvals were required for this acquisition.

Financial Performance of Trident Mediquip

The subsidiary has demonstrated consistent revenue growth over the past three financial years. The turnover figures for the last three years are as follows:

The disclosure was submitted by Nikita Sharma, Company Secretary and Compliance Officer of Trident Lifeline Limited, on June 16, 2026.